查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596749

滅菌指標市場：按類型、滅菌技術、最終用戶分類 - 全球預測 2025-2030

Sterility Indicators Market by Type (Biological, Chemical), Sterilization Technique (Filtration, Heat, Liquid), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，滅菌指標市場價值為9.3596億美元，預計到2024年將達到10.2815億美元，複合年成長率為9.92%，到2030年將達到18.148億美元。

無菌指示器是醫療和製藥業的重要工具，透過物理、化學和生物手段檢驗有效性，確保滅菌過程中的無菌性。這些指標對於醫院、診所和實驗室防止污染和確保病人安全至關重要。對無菌指標的需求是由嚴格的法規和不斷增強的感染控制意識推動的，強調在滅菌器、高壓釜和其他醫療設備測試中的應用。最終用途廣泛，包括醫療保健、製藥、醫療設備製造、食品和飲料以及研究機構。

主要市場統計
基準年[2023] 93596萬美元
預測年份 [2024] 1,028,150,000 美元
預測年份 [2030] 18.148 億美元
複合年成長率（%） 9.92%

無菌指標市場的成長主要受到醫院感染發生率上升、外科手術數量增加以及滅菌技術進步的影響。隨著醫療保健基礎設施的改善和更嚴格的監管標準的採用，新興市場存在巨大的成長機會。亞太地區製藥業的擴張和對食品安全的日益關注為市場擴張提供了進一步的機會。然而，該市場面臨局限性，例如無菌檢測程序成本高昂、低收入地區缺乏意識和培訓，以及遵守各種國際標準的挑戰。

為了創新，公司應專注於開發具有成本效益、更快、更準確的滅菌指示器，並將其整合到自動化滅菌過程中。提供即時資料追蹤和分析的增強數位解決方案提供了寶貴的成長途徑。奈米技術和生物技術的合作研究也可能帶來更好的無菌檢測方法。鑑於技術進步和監管變化的動態市場特徵，公司應積極參與研發夥伴關係並投資於培訓計劃，以更好地遵守和執行。對市場特定需求的策略關注和創新產品的徹底行銷可能是抓住成長機會和保持市場競爭力的關鍵。

市場動態：揭示快速發展的滅菌指標市場的關鍵市場洞察

供需的動態交互作用正在改變滅菌指示器市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 減少醫院感染的負擔增加
    • 醫藥產業研發快速成長
    • 不斷上漲的醫療費用和嚴格的政府健康和安全法規
  • 市場限制因素
    • 生物指示劑的局限性
  • 市場機會
    • 採用先進的無菌指標
    • 新產品的監管核准增加
  • 市場問題
    • 環氧乙烷滅菌的安全問題

波特五力：駕馭沖銷指標市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解滅菌指標市場的外部影響

外部宏觀環境因素在塑造沖銷指標市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解滅菌指示器市場的競爭格局

對滅菌指標市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣：滅菌指標市場供應商績效評估

FPNV 定位矩陣是評估滅菌指標市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃沖銷指標市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對滅菌指標市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 減少醫院感染的負擔增加
      • 製藥業研發活動快速成長
      • 不斷上漲的醫療費用和嚴格的政府健康和安全法規
    • 抑制因素
      • 與生物指標相關的局限性
    • 機會
      • 採用先進的滅菌指標
      • 新產品的監管核准增加
    • 任務
      • 環氧乙烷滅菌的安全問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 沖銷指標市場：依類型

  • 介紹
  • 生物
    • 自足式管瓶
    • 孢子安瓿
    • 孢子條
    • 孢子懸浮液
  • 化學
    • 1級
    • 2級
    • 3級
    • 4級
    • 5級

第7章 滅菌指標市場：依滅菌技術分類

  • 介紹
  • 濾
  • 熱
  • 液體
  • 低溫
  • 輻射

第8章滅菌指標市場：依最終用戶分類

  • 介紹
  • 臨床實驗室/研究中心
  • 醫院
  • 醫療設備公司
  • 製藥公司

第9章 美洲滅菌指標市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太對沖指標市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲滅菌指標市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Andersen Products, Inc.
  • Anqing Kangmingna Packaging Co., Ltd.
  • ANTONIO MATACHANA, SA
  • Cantel Medical Corporation
  • Cardinal Health, Inc.
  • Crosstex International, Inc.
  • Etigam BV
  • Fortive Corporation
  • Getinge AB
  • GKE GmbH
  • Hu-Friedy Mfg. Co., LLC
  • Liofilchem Srl
  • Mesa Labs, Inc.
  • MMM Group
  • National Analytical Corporation
  • Nelson Laboratories, LLC
  • NiGK Corporation
  • Noxilizer, Inc.
  • Propper Manufacturing Co., Inc.
  • Sterigenics Germany GmbH
  • STERIS
  • Tapecon, Inc.
  • Thermo Fisher Scientific Inc.
  • Visumed Equipments
Product Code: MRR-C002B1C9961C

The Sterility Indicators Market was valued at USD 935.96 million in 2023, expected to reach USD 1,028.15 million in 2024, and is projected to grow at a CAGR of 9.92%, to USD 1,814.80 million by 2030.

Sterility indicators are critical tools in healthcare and pharmaceutical industries, ensuring sterile conditions during the sterilization processes by validating the effectiveness through physical, chemical, and biological means. These indicators are essential in hospitals, clinics, and laboratories to prevent contamination and ensure patient safety. The necessity for sterility indicators is driven by stringent regulations and heightened awareness about infection control, underscoring their application in sterilizers, autoclaves, and other medical equipment checks. The end-use scope spans across healthcare, pharmaceuticals, medical device manufacturing, food & beverage industry, and research organizations.

KEY MARKET STATISTICS
Base Year [2023] USD 935.96 million
Estimated Year [2024] USD 1,028.15 million
Forecast Year [2030] USD 1,814.80 million
CAGR (%) 9.92%

Market growth for sterility indicators is primarily influenced by the rising incidence of hospital-acquired infections, increasing surgical procedures, and advancements in sterilization technologies. Significant growth opportunities lie in emerging markets as healthcare infrastructure improves and adopts stricter regulatory standards. An expanding pharmaceutical sector in APAC and increasing focus on food safety further present opportunities for market expansion. However, the market faces limitations like high costs of sterility testing procedures and lack of awareness and training in low-income regions, along with challenges related to compliance with diverse international standards.

For innovation, businesses should focus on developing cost-effective, rapid, and more accurate sterility indicators that integrate with automated sterilization processes. Enhanced digital solutions offering real-time data tracking and analytics present valuable growth avenues. Collaborative research in nanotechnology and biotechnology could also lead to superior sterility testing methodologies. Given the dynamic market nature, characterized by technological advancements and regulatory shifts, companies should actively engage in R&D partnerships and invest in training programs for better compliance and implementation. A strategic focus on market-specific needs and rigorous marketing of innovative products will be key to capturing growth opportunities and maintaining a competitive edge in the sterility indicators market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Sterility Indicators Market

The Sterility Indicators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing burden to reduce hospital acquired infections
    • Surging research & development activities in pharmaceutical sector
    • Escalating healthcare costs and strict government hygiene and safety regulations
  • Market Restraints
    • Associated limitations of biological indicators
  • Market Opportunities
    • Introduction of advanced sterility indicators
    • Increase in regulatory approvals of novel products
  • Market Challenges
    • Safety concern related to ethylene oxide sterilization

Porter's Five Forces: A Strategic Tool for Navigating the Sterility Indicators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Sterility Indicators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Sterility Indicators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Sterility Indicators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Sterility Indicators Market

A detailed market share analysis in the Sterility Indicators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Sterility Indicators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Sterility Indicators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Sterility Indicators Market

A strategic analysis of the Sterility Indicators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Sterility Indicators Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Andersen Products, Inc., Anqing Kangmingna Packaging Co., Ltd., ANTONIO MATACHANA, S. A., Cantel Medical Corporation, Cardinal Health, Inc., Crosstex International, Inc., Etigam BV, Fortive Corporation, Getinge AB, GKE GmbH, Hu-Friedy Mfg. Co., LLC, Liofilchem S.r.l., Mesa Labs, Inc., MMM Group, National Analytical Corporation, Nelson Laboratories, LLC, NiGK Corporation, Noxilizer, Inc., Propper Manufacturing Co., Inc., Sterigenics Germany GmbH, STERIS, Tapecon, Inc., Thermo Fisher Scientific Inc., and Visumed Equipments.

Market Segmentation & Coverage

This research report categorizes the Sterility Indicators Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Biological and Chemical. The Biological is further studied across Self-contained Vials, Spore Ampoules, Spore Strips, and Spore Suspensions. The Chemical is further studied across Class 1, Class 2, Class 3, Class 4, and Class 5.
  • Based on Sterilization Technique, market is studied across Filtration, Heat, Liquid, Low Temperature, and Radiation.
  • Based on End-User, market is studied across Clinical Laboratories/Research Centers, Hospitals, Medical Device Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing burden to reduce hospital acquired infections
      • 5.1.1.2. Surging research & development activities in pharmaceutical sector
      • 5.1.1.3. Escalating healthcare costs and strict government hygiene and safety regulations
    • 5.1.2. Restraints
      • 5.1.2.1. Associated limitations of biological indicators
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced sterility indicators
      • 5.1.3.2. Increase in regulatory approvals of novel products
    • 5.1.4. Challenges
      • 5.1.4.1. Safety concern related to ethylene oxide sterilization
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Sterility Indicators Market, by Type

  • 6.1. Introduction
  • 6.2. Biological
    • 6.2.1. Self-contained Vials
    • 6.2.2. Spore Ampoules
    • 6.2.3. Spore Strips
    • 6.2.4. Spore Suspensions
  • 6.3. Chemical
    • 6.3.1. Class 1
    • 6.3.2. Class 2
    • 6.3.3. Class 3
    • 6.3.4. Class 4
    • 6.3.5. Class 5

7. Sterility Indicators Market, by Sterilization Technique

  • 7.1. Introduction
  • 7.2. Filtration
  • 7.3. Heat
  • 7.4. Liquid
  • 7.5. Low Temperature
  • 7.6. Radiation

8. Sterility Indicators Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinical Laboratories/Research Centers
  • 8.3. Hospitals
  • 8.4. Medical Device Companies
  • 8.5. Pharmaceutical Companies

9. Americas Sterility Indicators Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Sterility Indicators Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Sterility Indicators Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Andersen Products, Inc.
  • 3. Anqing Kangmingna Packaging Co., Ltd.
  • 4. ANTONIO MATACHANA, S. A.
  • 5. Cantel Medical Corporation
  • 6. Cardinal Health, Inc.
  • 7. Crosstex International, Inc.
  • 8. Etigam BV
  • 9. Fortive Corporation
  • 10. Getinge AB
  • 11. GKE GmbH
  • 12. Hu-Friedy Mfg. Co., LLC
  • 13. Liofilchem S.r.l.
  • 14. Mesa Labs, Inc.
  • 15. MMM Group
  • 16. National Analytical Corporation
  • 17. Nelson Laboratories, LLC
  • 18. NiGK Corporation
  • 19. Noxilizer, Inc.
  • 20. Propper Manufacturing Co., Inc.
  • 21. Sterigenics Germany GmbH
  • 22. STERIS
  • 23. Tapecon, Inc.
  • 24. Thermo Fisher Scientific Inc.
  • 25. Visumed Equipments

LIST OF FIGURES

  • FIGURE 1. STERILITY INDICATORS MARKET RESEARCH PROCESS
  • FIGURE 2. STERILITY INDICATORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STERILITY INDICATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STERILITY INDICATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STERILITY INDICATORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STERILITY INDICATORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STERILITY INDICATORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STERILITY INDICATORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES STERILITY INDICATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES STERILITY INDICATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. STERILITY INDICATORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. STERILITY INDICATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STERILITY INDICATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STERILITY INDICATORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STERILITY INDICATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STERILITY INDICATORS MARKET DYNAMICS
  • TABLE 7. GLOBAL STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STERILITY INDICATORS MARKET SIZE, BY SELF-CONTAINED VIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STERILITY INDICATORS MARKET SIZE, BY SPORE AMPOULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STERILITY INDICATORS MARKET SIZE, BY SPORE STRIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STERILITY INDICATORS MARKET SIZE, BY SPORE SUSPENSIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STERILITY INDICATORS MARKET SIZE, BY CLASS 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STERILITY INDICATORS MARKET SIZE, BY CLASS 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STERILITY INDICATORS MARKET SIZE, BY CLASS 3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STERILITY INDICATORS MARKET SIZE, BY CLASS 4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL STERILITY INDICATORS MARKET SIZE, BY CLASS 5, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL STERILITY INDICATORS MARKET SIZE, BY FILTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL STERILITY INDICATORS MARKET SIZE, BY HEAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL STERILITY INDICATORS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL STERILITY INDICATORS MARKET SIZE, BY LOW TEMPERATURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL STERILITY INDICATORS MARKET SIZE, BY RADIATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL STERILITY INDICATORS MARKET SIZE, BY CLINICAL LABORATORIES/RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL STERILITY INDICATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL STERILITY INDICATORS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL STERILITY INDICATORS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES STERILITY INDICATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA STERILITY INDICATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM STERILITY INDICATORS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM STERILITY INDICATORS MARKET SIZE, BY BIOLOGICAL, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM STERILITY INDICATORS MARKET SIZE, BY CHEMICAL, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM STERILITY INDICATORS MARKET SIZE, BY STERILIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM STERILITY INDICATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. STERILITY INDICATORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 242. STERILITY INDICATORS MARKET, FPNV POSITIONING MATRIX, 2023